Startseite Study on a non-pharmacopeial formulation for its hepatoprotective activity against drug induced hepatotoxicity in animal model
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Study on a non-pharmacopeial formulation for its hepatoprotective activity against drug induced hepatotoxicity in animal model

  • Syeda Asma Firdose ORCID logo EMAIL logo und Abdul Wadud
Veröffentlicht/Copyright: 17. Oktober 2025

Abstract

Objectives

This study assessed the hepatoprotective efficacy of a non-pharmacopeial formulation (NPF) against rifampicin-induced hepatotoxicity, aiming to expand the repertoire of hepatoprotective agents in Unani medicine.

Methods

An acute toxicity study and HPTLC analysis were performed. The experiment utilized 42 Wistar rats, each weighing between 150 and 200 g. The rats were systematically allocated into seven distinct groups, each containing six animals, identified as negative, positive, standard, and test groups A, B, C, and D. Liver damage was induced by oral administration of rifampicin at a dose of 500 mg/kg daily for 30 days, following a 2-hour interval after the administration of standard and test drugs. The standard and test groups received Silymarin (100 mg/kg), NPF, Afsanteen, Kasni, and Asaroon at doses of 167, 117, 167, and 217 mg/kg, respectively, orally once daily for 30 days. Serum levels of marker enzymes (SGOT, SGPT, and ALP), total protein (TP), and albumin (S. Alb) were evaluated. All groups underwent biochemical and histopathological analysis.

Results

The formulation was deemed safe at a dose of up to 2000 mg/kg. Compared to the standard drug, test groups A and D demonstrated potential protective effects on the liver enzymes. Test groups B and C exhibited normal liver architecture.

Conclusions

Asaroon (test group D) demonstrated greater efficacy than NPF. Histopathologically, Afsanteen and Kasni were found to be effective. The study indicated that formulations by Unani scholars were more effective than non-pharmacopeial formulations, although the tested NPF remained effective and safe in this study.


Corresponding author: Syeda Asma Firdose, PhD. Scholar, Department of Ilmul Advia (Pharmacology), National Institute of Unani Medicine, Kottigepalya, Magadi main road, Bengaluru, 560091, India, E-mail:

Acknowledgments

Sincere gratitude is due to the HOD, Prof Ghulamuddin Sofi, Dept. of Ilmul Advia, NIUM for his guidance, and providing necessary infrastructure and support to conduct this research. I extend my heartfelt gratitude to my co-guide, Khaleequr Rahman, Associate Professor from the Department of Ilmul Saidla (Pharmacy) at NIUM, for his invaluable guidance and support throughout this study.

  1. Research ethics: IAEC Approval taken before the commencement of the study. IAEC/06/21/IA/01 dated 27/08/2022.

  2. Informed consent: Not applicable (Preclinical study).

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: Grammarly, Paperpal, and Quillbot were used for language, consistency, and paraphrasing.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: National Institute of Unani Medicine.

  7. Data availability: All the data has been shared. For the HPTLC, supplementary data has been shared.

References

1. Colledge, NR, Walker, BR, Ralston, SH. Davidson’s principles and practice of medicine, 21sted. Scotland: Edinburgh; New York: Churchill Livingstone/Elsevier; 2010.Suche in Google Scholar

2. Saukkonen, JJ, Cohn, DL, Jasmer, RM, Schenker, S, Jereb, JA, Nolan, CM, et al.. An official ATS statement: hepatotoxicity of anti-tuberculosis therapy. Am J Respir Crit Care Med 2006;174:935–52. https://doi.org/10.1164/rccm.200510-1666st.Suche in Google Scholar

3. Mohd, M, Sofi, G, Jahan, N, Baig, Z. Approaches for preparation methods of murakkab, an Unani formulation. J Ayurveda Integr Med 2019;10:302–7. https://doi.org/10.1016/j.jaim.2017.04.008.Suche in Google Scholar PubMed PubMed Central

4. Sina, I. Al-Qanoon-Fit-Tibb (Urdu translation by Kanturi GH). New Delhi: Idara Kitab-us-Shifa; YNM, vol II.Suche in Google Scholar

5. Kim, JH, Nam, WS, Kim, SJ, Kwon, OK, Seung, EJ, Jo, JJ, et al.. Mechanism investigation of rifampicin-induced liver injury using comparative toxicoproteomics in mice. Int J Mol Sci 2017;18:1417. https://doi.org/10.3390/ijms18071417.Suche in Google Scholar PubMed PubMed Central

6. Naik, SR, Panda, VS. Hepatoprotective effect of Ginkgoselect Phytosome® in rifampicin induced liver injurym in rats: evidence of antioxidant activity. Fitoter 2008;79:439–45. https://doi.org/10.1016/j.fitote.2008.02.013.Suche in Google Scholar PubMed

7. Abraham, A, Samuel, S, Mathew, L. Phytochemical analysis of pathyashadangam kwath and its standardization by HPLC and HPTLC. J Ayurveda Integr Med 2020;11:153–8. https://doi.org/10.1016/j.jaim.2017.10.011.Suche in Google Scholar PubMed PubMed Central

8. Ansari, S, Siddiqui, MA, Maaz, M, Khan, QA, Ahmad, I. Physiochemical standardization and HPTLC of artemisia absinthum, linn collected from khari baoli, Delhi. Indo Am J Pharm Res 2017;7:7681–8.Suche in Google Scholar

9. Khan, MA. Muheet e Azam. New Delhi: CCRUM, Ministry of Health & Family Welfare, Government of India; 2012, vol 1.Suche in Google Scholar

10. Khan, MA. Muheet e Azam. New Delhi: CCRUM, Ministry of Health & Family Welfare, Government of India; 2018, vol IV.Suche in Google Scholar

11. Ghani, N. Khazain-ul-Advia. New Delhi: Idara Kitab-us-Shifa; 2011.Suche in Google Scholar

12. Nair, AB, Jacob, S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016;7:27–31. https://doi.org/10.4103/0976-0105.177703.Suche in Google Scholar PubMed PubMed Central

13. OECD guidelines for testing chemicals 423 – Acute Oral Toxicity – Acute Toxic Class Method. Guidelines. Paris, France: The Organization for Economic Cooperation and Development (OECD); 2001:1–14 pp.Suche in Google Scholar

14. Jaeschke, H, Akakpo, JY, Umbaugh, DS, Ramachandran, A. Novel therapeutic approaches against acetaminophen-induced liver injury and acute liver failure. Toxicol Sci 2020;174:159–67. https://doi.org/10.1093/toxsci/kfaa002.Suche in Google Scholar PubMed PubMed Central

15. Wadud, A. Hepatoprotective effect of hydroalcoholic extract of qurse afsanteen, a polyherbal Unani formulation, in chemically induced hepatotoxicity in rat. Int J Green Pharm 2022;16.Suche in Google Scholar

16. Ma, Z, Zhang, B, Fan, Y, Wang, M, Kebebe, D, Li, J, et al.. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: a new strategy for the treatment of liver diseases. Biomed Pharmacother 2019;117:109128. https://doi.org/10.1016/j.biopha.2019.109128.Suche in Google Scholar PubMed

17. Gupta, A, Sheth, NR, Pandey, S, Shah, DR, Yadav, JS. Design and evaluation of herbal hepatoprotective formulation against paracetamol induced liver toxicity. J Young Pharm 2013;5:180–7. https://doi.org/10.1016/j.jyp.2013.12.003.Suche in Google Scholar PubMed PubMed Central

18. Mohan, H. Text book of pathology, 5th ed. New Delhi: JBMPL; 2005.Suche in Google Scholar

19. Francis, P, Navarro, VJ. Drug-induced hepatotoxicity. [updated 2024 sep 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. https://www.ncbi.nlm.nih.gov/books/NBK557535/.Suche in Google Scholar

20. Giannini, EG, Testa, R, Savarino, V. Liver enzyme alteration: a guide for clinicians. CMAJ (Can Med Assoc J) 2005;172:367–79. https://doi.org/10.1503/cmaj.1040752.Suche in Google Scholar PubMed PubMed Central

21. Parasuraman, S, Thing, GS, Dhanaraj, SA. Polyherbal formulation: concept of ayurveda. Pharmacogn Rev 2014;8:73. https://doi.org/10.4103/0973-7847.134229.Suche in Google Scholar PubMed PubMed Central

22. Ugwu, CE, Suru, MS. Traditional medicinal plants with significant protection against antitubercular drug-induced liver injury: a systematic review. Future Integr Med 2023;2:227–58. https://doi.org/10.14218/fim.2023.00043.Suche in Google Scholar

23. Shiffa, M, Aslam, M, Kazmi, MH, Ali, S, Fahamiya, N, Haque, MM. Physicochemical, phytochemical and HPTLC analysis of a novel combined herbal formulation. Int J Pharm Investig 2022;12:62–5. https://doi.org/10.5530/ijpi.2022.1.11.Suche in Google Scholar

24. Mohammadian, A, Moradkhani, S, Ataei, S, Shayesteh, TH, Sedaghat, M, Kheiripour, N, et al.. Antioxidative and hepatoprotective effects of hydroalcoholic extract of Artemisia absinthium L. in rat. J HerbMed Pharmacol 2016;5:29–32.Suche in Google Scholar

25. Amat, N, Upur, H, Blažeković, B. In vivo hepatoprotective activity of the aqueous extract of Artemisia absinthium L. against chemically and immunologically induced liver injuries in mice. J Ethnopharmacol 2010;131:478–84. https://doi.org/10.1016/j.jep.2010.07.023.Suche in Google Scholar PubMed

26. Sagástegui-Guarniz William Antonio, WA, Silva-Correa, CR, Torre, VL, Víctor, E, Cruzado-Razco, JL, Calderón-Peña, AA, et al.. Hepatoprotective and nephroprotective activity of Artemisia absinthium L. on diclofenac-induced toxicity in rats. Pharmacogn J 2020;12. https://doi.org/10.5530/pj.2020.12.146.Suche in Google Scholar

27. Heibatollah, S, Reza, NM, Izadpanah, G, Sohailla, S. Hepatoprotective effect of Cichorium intybus on CCl4-induced liver damage in rats. Afr J Biochem Res.9 2008;2:141–4.Suche in Google Scholar

28. Li, GY, Gao, HY, Huang, J, Lu, J, Gu, JK, Wang, JH. Hepatoprotective effect of Cichorium intybus L., a traditional uighur medicine, against carbon tetrachloride-induced hepatic fibrosis in rats. World J Gastroenterol: WJG 2014;20:4753. https://doi.org/10.3748/wjg.v20.i16.4753.Suche in Google Scholar PubMed PubMed Central

29. Amir, M, Ahmad, W, Sarafroz, M, Ahmad, A, Ali, A, Ansari, MA, et al.. Hepatoprotective effect of a polyherbal formulation (Aab-e-Murawaqain) against CCl4 induced liver toxicity in Wistar albino rat model by suppressing proinflammatory cytokines. South Afr J Bot 2022;151:75–81. https://doi.org/10.1016/j.sajb.2021.11.020.Suche in Google Scholar

30. Moloudi, MR, Hassanzadeh, K, Abdi, M, Zandi, F, Rahimi, K, Izadpanah, E. Hepatoprotective effect of the hydroalcoholic extract of Cichorium intybus in a rat model of obstructive cholestasis. Arab J Gastroenterol 2021;22:34–9. https://doi.org/10.1016/j.ajg.2020.08.006.Suche in Google Scholar PubMed

31. Tathe, PR, Jat, RK, Pathan, A, Biyani, K. Α-Asarone protects CCL4 induced hepatotoxicity in experimental rats by inhibiting oxidative stress and cytokines. J Drug Deliv Therapeut 2022;12:103–7. https://doi.org/10.22270/jddt.v12i3.5335.Suche in Google Scholar

32. Akhlaq, S, Ara, SA, Fazil, M, Ahmad, B, Akram, U, Haque, M, et al.. Ethnopharmacology, phytochemical analysis, safety profile, prophylactic aspects, and therapeutic potential of Asarum europaeum L. in Unani medicine: an evidence-based appraisal. Phytomed Plus 2022:100226. https://doi.org/10.1016/j.phyplu.2022.100226.Suche in Google Scholar


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/jcim-2025-0160).


Received: 2025-05-01
Accepted: 2025-09-18
Published Online: 2025-10-17

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 31.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jcim-2025-0160/pdf
Button zum nach oben scrollen